German Brain Tumour Association

DGAP-News: MagForce AG and Affiliated European Clinics Support World Brain Tumor Day and Sponsor Various Patient Events to Raise Awareness for One of the Deadliest Oncological Indications

Retrieved on: 
Friday, June 5, 2020
Cancer, Oncology, Health, Medicine, RTT, Brain tumor, Glioblastoma, Blastoma, German Brain Tumour Association, Metástasis, Brain metastasis, Neuro-Oncology

World Brain Tumor Day occures every year on June 8th to raise awareness and inspire hope for patients living with this disease.

Key Points: 
  • World Brain Tumor Day occures every year on June 8th to raise awareness and inspire hope for patients living with this disease.
  • Glioblastoma is the most common and aggressive form of brain tumors in adults with an incidence, i.e.
  • Additionally, many other types of cancer cause metastases in the brain, which are known as secondary brain tumors.
  • Alivia Cancer Foundation, SPSK4 Hospital in Lublin and MagForce invite you to a webinar for patients on the occasion of World Brain Tumor Day.

American Brain Tumor Association Invests $1.1 Million Across 18 Research Projects to Accelerate Brain Tumor Research for Adults and Children

Retrieved on: 
Monday, October 7, 2019
Brain tumor, American Brain Tumor Association, Health, ABTA, Cancer, Clinical medicine, Brain Tumor Funders' Collaborative, German Brain Tumour Association

CHICAGO, Oct. 7, 2019 /PRNewswire/ --As the nation's first nonprofit organization committed to funding brain tumor research and providing education and information on all tumor types, the American Brain Tumor Association (ABTA) today announced its investment of $1.1 million towards 18 new research grants to foster innovation in brain tumor diagnosis and treatment for adults and children.

Key Points: 
  • CHICAGO, Oct. 7, 2019 /PRNewswire/ --As the nation's first nonprofit organization committed to funding brain tumor research and providing education and information on all tumor types, the American Brain Tumor Association (ABTA) today announced its investment of $1.1 million towards 18 new research grants to foster innovation in brain tumor diagnosis and treatment for adults and children.
  • With minimal government funding for brain tumor research, the ABTA's grant program plays an integral role in advancing the understanding and treatment of brain tumors.
  • ABTA Research Collaboration Grants are two-year, $200,000 grants supporting multiple investigators undertaking multi-disciplinary research projects in the brain tumor field.
  • Founded in 1973, the American Brain Tumor Association was the first national patient advocacy organization committed to funding brain tumor research and providing support and education programs for patients, caregivers and their loved ones.